As of 2025-02-17, the Relative Valuation of Antares Pharma Inc (ATRS) is 6.93 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 24.0%.
The range of the Relative Valuation is 5.80 - 8.24 USD.
Range | Selected | |
Trailing P/E multiples | - | - |
Forward P/E multiples | 17.4x - 24.7x | 20.8x |
Fair Price | 5.80 - 8.24 | 6.93 |
Upside | 3.8% - 47.4% | 24.0% |
Date | P/E |